Transdermal drug delivery system for delivering a drug to a patient

A transdermal drug delivery system for delivering a drug to a patient comprising:

• a backing layer;
• an adhesive layer;
• a topical applicator;
• a suitable quantity of drug;
• a quantity of topical carrier;
• a hydrogel homogenizer;
• the backing layer being a piece of medical tape;
• the topical applicator comprising a flat applicator body, a plurality of blunted spikes, and a containment rim;
• the suitable quantity of drug and the quantity of topical carrier being homogenously mixed together as a topical medication;
• the adhesive layer being positioned in between the backing layer and the flat applicator body;
• the flat applicator body being connected across and against the backing layer by the adhesive layer;
• the containment rim and the plurality of blunted spikes being positioned adjacent to the flat applicator body, opposite to the backing layer;
• the plurality of blunted spikes being connected onto the flat applicator body;
• the plurality of blunted spikes being distributed across the flat applicator body;
• the plurality of blunted spikes being oriented away from the flat applicator body;
• the containment rim being peripherally connected to the flat applicator body;
• the containment rim being positioned around the plurality of blunted spikes;
• the topical medication being retained within the containment rim;
• the topical medication being retained amongst the plurality of blunted spikes;
• the quantity of topical carrier comprising at least one quantity of gelling agent, at least one quantity of skin-penetrating enhancer, at least one quantity of buffering agent, at least one quantity of stabilizer, and a quantity of water, wherein the quantity of water is approximately 41.0 percentage by weight (wt. %) of the topical medication;
• the at least one quantity of gelling agent, the at least one quantity of skin-penetrating enhancer, the at least one quantity of buffering agent, the at least one quantity of stabilizer, and the quantity of water being homogenously mixed together with the hydrogel homogenizer;
• the suitable quantity of drug being a quantity of ibuprofen, wherein the quantity of ibuprofen is approximately 4.0 wt. % of the topical medication;
• the at least one gelling agent being a quantity of xanthan gum and a quantity of carbomer, wherein the quantity of xanthan gum is approximately 1.0 wt. % of the topical medication, and wherein the quantity of carbomer is approximately 0.2 wt. % of the topical medication;
• the at least one quantity of skin-penetrating enhancer being a quantity of ethanol and a quantity of glycerin, wherein the quantity of ethanol is approximately 40.0 wt. % of the topical medication, and wherein the quantity of glycerin is approximately 10.5 wt. % of the topical medication;
• the at least one quantity of buffering agent being a quantity of sodium carbonate, wherein the quantity of sodium carbonate is approximately 0.35 wt. % of the topical medication;
• and
• the at least one quantity of stabilizer being a quantity of polyethylene glycol, wherein the quantity of polyethylene glycol is approximately 3 wt. % of the topical medication.